For example, within the subgroup comprising pancreatic cancer patients classified as either CagA-nonendemic or CagA endemic and COVID-19 patients with hospitalization, we found the results from subgroup analyses were consistent with the main findings. This evidence concerns the gene S100A8 and familial pancreatic carcinoma.